Drug intelligence / Profile preview

autologous bone marrow mesenchymal stem cells (Ukraine Association of Biobank)

Development stage
Unknown
Lead developer
Ukraine Association of Biobank
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

This investigational autologous cell therapy consists of bone marrow-derived mesenchymal stem cells (BM-MSCs) developed by the Ukraine Association of Biobank for the treatment of liver cirrhosis. The therapy involves harvesting 100-200ml of bone marrow from the patient, processing it to isolate multipotent stromal cells, and re-infusing them into the patient. These mesenchymal stem cells are intended to treat compensated liver cirrhosis caused by Hepatitis B, Hepatitis C, or Nonalcoholic Steatohepatitis (NASH). The therapeutic mechanism is multifaceted, involving immunomodulation, anti-fibrotic signaling, and the potential differentiation of the stem cells into functional hepatocyte-like cells to promote hepatic regeneration and reduce liver scarring.

Other names
Autologous BM MSCAutologous Mesenchymal Stem Cell Therapy

Beyond the preview

Go deeper on autologous bone marrow mesenchymal stem cells (Ukraine Association of Biobank).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous bone marrow mesenchymal stem cells (Ukraine Association of Biobank).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call